Skip to main content
. 2017 May 4;35(22):2482–2489. doi: 10.1200/JCO.2017.72.3742

Fig 1.

Fig 1.

Annual targeted oral anticancer medication costs of Medicare Part D beneficiaries, 2007 to 2012. (A) Mean costs per patient per month (PPPM); (B) median costs PPPM; (C) costs PPPM at 75th percentile; (D) costs PPPM at 95th percentile. LIS, low-income subsidy; OOP, out-of-pocket.